EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Procedure‐specific morbidity and pathologic assessment after resection of small (≤20 mm) pancreatic neuroendocrine tumors

Aya Maekawa iD, Giampaolo Perri iD, Stefano Partelli, Charles de Ponthaud iD, Safi Dokmak, Carsten Jäger, Maria Lavinia Luzietti iD, Alessio Marchetti iD, Valentina Andreasi iD, Anna Battistella iD, Bengi Su Yilmaz, Andrea Sheel iD und 9 weitere

Journal of Neuroendocrinology · 2026

DOI: 10.1111/jne.70243 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neuroendocrinology, 2026. Verfasst von Aya Maekawa und 20 weiteren Autor:innen. Beteiligte Einrichtung: Hepato-Pancreato-Biliary and Liver Transplant Surgery Unit, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University…. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Pancreatectomy, Pancreatic Neoplasms, Pancreaticoduodenectomy. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic neuroendocrine tumors (PanNETs) are increasingly detected, and the optimal extent of resection remains uncertain because perioperative burden and oncologic assessment may differ by procedure. Enucleation (EN) and central pancreatectomy (CP) are often grouped together as parenchyma‐sparing resections (PSRs) despite substantial differences in technical complexity, postoperative risk, and oncologic evaluation.We conducted a multicenter retrospective study of consecutive patients who underwent resection for pathologically confirmed PanNETs ≤20 mm. Procedures were categorized as EN, CP, pancreatoduodenectomy (PD), total pancreatectomy (TP), or distal pancreatectomy (DP). Primary outcomes were clinically relevant postoperative pancreatic fistula (CR‐POPF) and major morbidity, defined as Clavien‐Dindo grade ≥IIIa. A prespecified pairwise comparison focused on EN and CP, and pathologic assessment patterns were analyzed descriptively across procedures. Of 460 patients, 164 (35.7%) underwent EN, 40 (8.7%) CP, 84 (18.2%) PD/TP, and 172 (37.4%) DP. CR‐POPF occurred in 115 patients (25.0%), major morbidity in 68 (14.8%), and 90‐day mortality in 4 (0.9%). Among PSRs, CP had higher major morbidity than EN (25.0% vs 10.4%, p =.020), higher CR‐POPF (50.0% vs. 24.4%, p =.003), and a longer median hospital stay (19.5 vs. 10.0 days, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsPancreatectomyPancreatic NeoplasmsPancreaticoduodenectomyPostoperative ComplicationsAdultAgedFemaleHumansMaleMiddle AgedMorbidityPancreatic FistulaRetrospective Studies

Stichwörter der Autor:innen

central pancreatectomyenucleationmorbiditypancreatic neuroendocrine tumorspostoperative pancreatic fistula

Autor:innen und Institutionen

  • Hepato-Pancreato-Biliary and Liver Transplant Surgery Unit, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, Padua, Italy.
  • Pancreatic and Transplantation Surgical Unit, IRCCS San Raffaele Hospital, Vita-Salute University, Milan, Italy.
  • Department of Pancreatic Surgery, Pitié-Salpétrière Hospital, AP-HP, Paris, France.
  • Department of HPB Surgery and Liver Transplantation, Beaujon Hospital, AP-HP Nord, Université Paris Cité, CRI-INSERM UMR 1149, Clichy, France.
  • Department of Surgery, School of Medicine and Health, TUM University Hospital, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
  • Department of Pancreatic Surgery, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.

ORCID-Profile: Aya Maekawa, Giampaolo Perri, Charles de Ponthaud, Maria Lavinia Luzietti, Alessio Marchetti, Valentina Andreasi, Anna Battistella, Andrea Sheel, Kunal Rajput, Umberto Cillo, Alain Sauvanet, Helmut Friess, Sébastien Gaujoux, Massimo Falconi, Giovanni Marchegiani

Zitieren

APA

Maekawa, A., Perri, G., Partelli, S., de Ponthaud, C., Dokmak, S., Jäger, C., Luzietti, M. L., Marchetti, A., Andreasi, V., Battistella, A., Yilmaz, B. S., Sheel, A., Rajput, K., Hu, H., Cillo, U., Sauvanet, A., Friess, H., Baron, R. D., Gaujoux, S., …, & Marchegiani, G. (2026). Procedure‐specific morbidity and pathologic assessment after resection of small (≤20 mm) pancreatic neuroendocrine tumors. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.70243

Vancouver

Maekawa A, Perri G, Partelli S, de Ponthaud C, Dokmak S, Jäger C, et al. Procedure‐specific morbidity and pathologic assessment after resection of small (≤20 mm) pancreatic neuroendocrine tumors. Journal of Neuroendocrinology. 2026. doi:10.1111/jne.70243

BibTeX
@article{Maekawa2026,
  author = {Maekawa, Aya and Perri, Giampaolo and Partelli, Stefano and de Ponthaud, Charles and Dokmak, Safi and Jäger, Carsten and Luzietti, Maria Lavinia and Marchetti, Alessio and Andreasi, Valentina and Battistella, Anna and Yilmaz, Bengi Su and Sheel, Andrea and Rajput, Kunal and Hu, Haiyi and Cillo, Umberto and Sauvanet, Alain and Friess, Helmut and Baron, Ryan D and Gaujoux, Sébastien and Falconi, Massimo and Marchegiani, Giovanni},
  title = {Procedure‐specific morbidity and pathologic assessment after resection of small (≤20 mm) pancreatic neuroendocrine tumors},
  journal = {Journal of Neuroendocrinology},
  year = {2026},
  doi = {10.1111/jne.70243}
}
Kostenlos starten →